Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • give logo Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Dates and Deadlines
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Guidelines for Participating in SfN Events
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2024 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Attend
      • Read
      • Watch
      • Listen
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Diversity Initiatives
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
101 - 110 of 890 results
  • Abstract
    Tetrahydrocannabinol enhances spontaneous pain in a rat model of inflammatory bowel disease
    Inflammatory Bowel Disease (IBD) is a lifelong condition that often begins between the ages of 15 and 30 and includes chronic pain as a major symptom. Treatment options are limited because NSAIDs and opioids have adverse effects. Although anecdotal repo...
    Oct 19, 2019
  • Abstract
    Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine 1A receptor-dependent mechanism.
    BACKGROUND AND PURPOSE: Cannabidiol has been reported to be a neuroprotectant, but the neuroprotective mechanism of cannabidiol remains unclear. We studied the neuroprotective mechanism of cannabidiol in 4-hour middle cerebral artery (MCA) occlusion mice. METHODS: Male MCA occluded mice were treated with cannabidiol, abnormal cannabidiol, anandamide, methanandamide, cannabidiol plus capsazepine, and cannabidiol plus WAY100135 before and 3 hours after MCA occlusion. The infarct size was determined after 24 hours (2,3,5-triphenyltetrazolium chloride staining). Cerebral blood flow (CBF) was measured at, before and 1, 2, 3, and 4 hours after MCA occlusion. RESULTS: Cannabidiol significantly reduced the infarct volume induced by MCA occlusion in a bell-shaped curve. Similarly, abnormal cannabidiol but not anandamide or methanandamide reduced the infarct volume. Moreover, the neuroprotective effect of cannabidiol was inhibited by WAY100135, a serotonin 5-hydroxytriptamine1A (5-HT1A) receptor antagonist but not c...
    Nov 12, 2005
  • Abstract
    Deficits in a rodent attentional set-shifting task induced by repeated THC administration.
    Cannabis use has been associated with deficits in prefrontal- cortex dependent cognitive processes in humans. We have previously shown that acute administration of Δ9-tetrahydrocannabinol (THC) produces deficits in reversal learning (REV) and the ability to shift attention within a perceptual dimension (intradimensional shift, IDS) in an attentional set shifting task (ASST) (Egerton et al., Program No. 110.15 2003 Abstract viewer/Itinerary Planner. Washington, DC: Society for Neuroscience). However, the human literature suggests that cannabis-induced cognitive deficits are more apparent following chronic use. We therefore employed the ASST to test the hypothesis that a chronic intermittent THC treatment regime would lead to deficits in executive function that were different from those induced by acute treatment. Long Evans hooded rats were administered THC (1mg/kg i.p.) or vehicle once per week for 4 weeks and tested in the ASST 30 minutes after the last dose of THC or vehicle. Chronic intermittent THC pro...
    Oct 26, 2004
  • Abstract
    Effect of Δ9-tetrahydrocannabinol on CREB phosphorylation in rat cerebellum: An immunohistochemical study.
    Numerous CNS processes, including neurotransmitter synthesis, gene expression, and cellular proliferation are controlled by neurotransmitters acting through second messenger systems that phosphorylate the transcription factor cyclic AMP response element-binding protein (CREB). Several converging lines of evidence indicate that drug of abuse may exert their profound long-term effects on the CNS by modulating signaling pathways controlling gene expression. Cannabinoids produce locomotor effects that include hypolocomotion, ataxia and catalepsy mediated by CB1 cannabinoids receptors located in motor control regions and cognitive impairment. Since there is evidence that cerebellum have a role not only in motor function but also in cognition, the purpose of the present study was to examine the effect of the Δ9-tetrahydrocannabinol (Δ9-THC), the principal psychoactive component of marijuana, on the phosphorylation of CREB in rat cerebellum, which present an high density of cannabinoids CB1 receptors and to deter...
    Oct 26, 2004
  • Abstract
    δ-9-Tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in suncus murinus: an animal model of anticipatory nausea and vomiting (ANV).
    Chemotherapy patients report not only acute nausea and vomiting during the treatment itself, but also report anticipatory nausea and vomiting upon re-exposure to the cues associated with the treatment. We present a model of anticipatory nausea based on the emetic reactions of the Suncus murinus (musk shrew). Following three pairings of a novel distinctive contextual cue with the emetic effects of an injection of lithium chloride, the context acquired the potential to elicit conditioned retching in the absence of the toxin. The expression of this conditioned retching reaction was completely suppressed by pretreatment with each of the principal cannabinoids found in marijuana, δ9-tetrahydrocannabinol or cannabidiol, at a dose that did not suppress general activity. On the other hand, pretreatment with a dose of ondansetron (a 5-HT3 antagonist) that interferes with acute vomiting in this species, did not suppress the expression of conditioned retching during re-exposure to the lithium-paired context. These re...
    Nov 14, 2005
  • Abstract
    Molecular determinants of Δ9-tetrahydrocannabinol-induced potentiation of glycine α1 receptors
    The glycine receptors (GlyR) are inhibitory ligand-gated ion channels in the central nervous system that have roles in motor coordination, antinociception and reward mechanisms. The function of GlyRs can be modulated by various protein kinases, interact...
    Nov 7, 2007
  • Abstract
    Chronic THC exposure: effects on sucrose self-administration in adolescent rats
    Drug use and feeding are both reinforced through powerful rewards of the dopaminergic system (Volkow and Wise, 2005). Particularly, early developmental processes seem to influence both the consumption of food and drug abuse later in life. For example, m...
    Nov 6, 2007
  • Abstract
    Cytochrome polymorphisms in the therapeutic response of cannabidiol in patients with drug-resistant epilepsy
    Abstract: Problem statement: In Mexico, 30% of epileptic patients are resistant to drug treatment. (Perez Almengor., et; al, 2015). Given the low response to current anti-epileptic drugs (AEDs) for the control of drug-resistant epileptic seizures, the u...
    Nov 11, 2021
  • Abstract
    Global DNA methylation variation induced by cannabidiol in cerebral cortex of rats
    Several pieces of evidence have shown that the non-psychoactive compound of marihuana, cannabidiol (CBD), displays wake-promoting properties. Our group has reported that central microinjections of CBD promotes wakefulness and decreases sleep in rats dur...
    Nov 16, 2016
  • Abstract
    Hypothamic cells show increased methylation to the administration of CBD in rats.
    Cannabis plants have been used long ago as it is known to have a potential effect on the human nervous system. Recently used in neurological treatments showing great efficiency. Here, we describe an experiment using Male Wistar rats (n=9) where they wer...
    Nov 16, 2016
  • Previous
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next

Featured

  • Watch: The Inspiration Behind the Neuroscience 2025 Logo
  • Upcoming Webinar: JNeurosci Town Hall
  • Find a Roommate for Neuroscience 2025 in the Roommate Matching Forum
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience